MX2010003757A - Composiciones que comprenden multimeros optimizados de her1 y her3 y sus metodos de uso. - Google Patents
Composiciones que comprenden multimeros optimizados de her1 y her3 y sus metodos de uso.Info
- Publication number
- MX2010003757A MX2010003757A MX2010003757A MX2010003757A MX2010003757A MX 2010003757 A MX2010003757 A MX 2010003757A MX 2010003757 A MX2010003757 A MX 2010003757A MX 2010003757 A MX2010003757 A MX 2010003757A MX 2010003757 A MX2010003757 A MX 2010003757A
- Authority
- MX
- Mexico
- Prior art keywords
- her3
- multimers
- optimized
- compositions
- her1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Abstract
La invenci?n proporciona composiciones que comprenden mult?meros de Her3 manipulados gen?ticamente con una afinidad de uni?n mejorada. Los mult?meros incluyen, entre otras cosas, los heterod?meros de Herl/Her3 en los cuales el dominio de uni?n al ligando de Her3 ha sido optimizado para aumentar la uni?n a Her3 La composici?n tambi?n puede incluir mezclas de homod?meros de Herl, homod?meros de Her3 y heterod?meros de Herl/Her3.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98042407P | 2007-10-16 | 2007-10-16 | |
US4330808P | 2008-04-08 | 2008-04-08 | |
PCT/US2008/079998 WO2009052184A2 (en) | 2007-10-16 | 2008-10-15 | Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010003757A true MX2010003757A (es) | 2010-04-27 |
Family
ID=40254392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010003757A MX2010003757A (es) | 2007-10-16 | 2008-10-15 | Composiciones que comprenden multimeros optimizados de her1 y her3 y sus metodos de uso. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100278801A1 (es) |
EP (1) | EP2205629A2 (es) |
JP (1) | JP2011500703A (es) |
KR (1) | KR20100082775A (es) |
CN (1) | CN101827860A (es) |
AU (1) | AU2008312580A1 (es) |
BR (1) | BRPI0818033A2 (es) |
CA (1) | CA2702740A1 (es) |
MX (1) | MX2010003757A (es) |
RU (1) | RU2010119556A (es) |
TW (1) | TW200932257A (es) |
WO (1) | WO2009052184A2 (es) |
ZA (1) | ZA201001880B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9139825B2 (en) | 2009-10-30 | 2015-09-22 | Novartis Ag | Universal fibronectin type III bottom-side binding domain libraries |
JP5981853B2 (ja) | 2010-02-18 | 2016-08-31 | ジェネンテック, インコーポレイテッド | ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用 |
AU2011283646B2 (en) | 2010-07-30 | 2015-07-09 | Novartis Ag | Fibronectin cradle molecules and libraries thereof |
CU24094B1 (es) | 2010-08-20 | 2015-04-29 | Novartis Ag | Anticuerpos para el receptor 3 del factor de crecimiento epidérmico(her3) |
US9522951B2 (en) | 2011-10-31 | 2016-12-20 | Bristol-Myers Squibb Company | Fibronectin binding domains with reduced immunogenicity |
EP3774859B1 (en) | 2018-04-11 | 2024-03-13 | Salubris Biotherapeutics, Inc. | Human neuregulin-1 (nrg-1) recombinant fusion protein compositions and methods of use thereof |
WO2023168426A1 (en) * | 2022-03-03 | 2023-09-07 | Enosi Therapeutics Corporation | Compositions and cells containing mixtures of oligo-trap fusion proteins (ofps) and uses thereof |
EP4324846A1 (en) | 2022-08-16 | 2024-02-21 | Eberhard Karls Universität Tübingen, Medizinische Fakultät | Inhibitor protein of ligands of epidermal growth factor receptor (egfr) |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3630200A (en) * | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
US3636809A (en) * | 1969-07-10 | 1972-01-25 | Nippon Musical Instruments Mfg | Stringed musical instrument |
US3847770A (en) * | 1972-04-10 | 1974-11-12 | Continental Can Co | Photopolymerizable compositions prepared from beta hydroxy esters and polyitaconates |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
AU3934085A (en) * | 1984-01-30 | 1985-08-09 | Icrf Patents Ltd. | Improvements relating to growth factors |
US4931373A (en) * | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
US4769027A (en) * | 1984-08-15 | 1988-09-06 | Burroughs Wellcome Co. | Delivery system |
US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
US4935233A (en) * | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
US4687610A (en) * | 1986-04-30 | 1987-08-18 | E. I. Du Pont De Neumours And Company | Low crystallinity polyester yarn produced at ultra high spinning speeds |
US5401638A (en) * | 1986-06-04 | 1995-03-28 | Oncogene Science, Inc. | Detection and quantification of neu related proteins in the biological fluids of humans |
ATE80165T1 (de) * | 1987-10-09 | 1992-09-15 | Vincenzo Zappia | Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten. |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
IT1229203B (it) * | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) * | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5723286A (en) * | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
US6136310A (en) * | 1991-07-25 | 2000-10-24 | Idec Pharmaceuticals Corporation | Recombinant anti-CD4 antibodies for human therapy |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5792771A (en) * | 1992-11-13 | 1998-08-11 | Sugen, Inc. | Quinazoline compounds and compositions thereof for the treatment of disease |
US5591767A (en) * | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
US5354566A (en) * | 1993-06-02 | 1994-10-11 | Kraft General Foods, Inc. | Preparation of yeast-leavened dough crusts |
US5994341A (en) * | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
US5457035A (en) * | 1993-07-23 | 1995-10-10 | Immunex Corporation | Cytokine which is a ligand for OX40 |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
IT1270594B (it) * | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US5639757A (en) * | 1995-05-23 | 1997-06-17 | Pfizer Inc. | 4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors |
CA2258721C (en) * | 1996-07-12 | 2014-09-09 | Genentech, Inc. | Chimeric heteromultimer adhesins |
US6417168B1 (en) * | 1998-03-04 | 2002-07-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods of treating tumors |
US7173005B2 (en) * | 1998-09-02 | 2007-02-06 | Antyra Inc. | Insulin and IGF-1 receptor agonists and antagonists |
US7396810B1 (en) * | 2000-08-14 | 2008-07-08 | Oregon Health Sciences University | Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
US7393823B1 (en) * | 1999-01-20 | 2008-07-01 | Oregon Health And Science University | HER-2 binding antagonists |
US8188231B2 (en) * | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
WO2005016966A2 (en) * | 2003-05-16 | 2005-02-24 | Receptor Biologix, Inc. | Intron fusion proteins, and methods of identifying and using same |
US20050123538A1 (en) * | 2003-10-03 | 2005-06-09 | Ronen Shemesh | Polynucleotides encoding novel ErbB-2 polypeptides and kits and methods using same |
WO2006119510A2 (en) * | 2005-05-04 | 2006-11-09 | Receptor Biologix, Inc. | Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same |
NZ574093A (en) * | 2006-06-12 | 2011-03-31 | Symphogen As | Pan-cell surface receptor- specific therapeutics |
-
2008
- 2008-10-15 US US12/682,584 patent/US20100278801A1/en not_active Abandoned
- 2008-10-15 EP EP08838760A patent/EP2205629A2/en not_active Withdrawn
- 2008-10-15 TW TW097139645A patent/TW200932257A/zh unknown
- 2008-10-15 MX MX2010003757A patent/MX2010003757A/es unknown
- 2008-10-15 JP JP2010530084A patent/JP2011500703A/ja not_active Withdrawn
- 2008-10-15 CA CA2702740A patent/CA2702740A1/en not_active Abandoned
- 2008-10-15 AU AU2008312580A patent/AU2008312580A1/en not_active Abandoned
- 2008-10-15 RU RU2010119556/10A patent/RU2010119556A/ru not_active Application Discontinuation
- 2008-10-15 KR KR1020107007386A patent/KR20100082775A/ko not_active Application Discontinuation
- 2008-10-15 WO PCT/US2008/079998 patent/WO2009052184A2/en active Application Filing
- 2008-10-15 BR BRPI0818033 patent/BRPI0818033A2/pt not_active IP Right Cessation
- 2008-10-15 CN CN200880112006A patent/CN101827860A/zh active Pending
-
2010
- 2010-03-16 ZA ZA2010/01880A patent/ZA201001880B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201001880B (en) | 2011-10-26 |
TW200932257A (en) | 2009-08-01 |
KR20100082775A (ko) | 2010-07-19 |
WO2009052184A3 (en) | 2009-06-11 |
BRPI0818033A2 (pt) | 2015-03-24 |
CA2702740A1 (en) | 2009-04-23 |
RU2010119556A (ru) | 2011-11-27 |
WO2009052184A2 (en) | 2009-04-23 |
JP2011500703A (ja) | 2011-01-06 |
AU2008312580A1 (en) | 2009-04-23 |
US20100278801A1 (en) | 2010-11-04 |
EP2205629A2 (en) | 2010-07-14 |
CN101827860A (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010003757A (es) | Composiciones que comprenden multimeros optimizados de her1 y her3 y sus metodos de uso. | |
WO2007024921A3 (en) | Combination therapies for inhibiting integrin-extracellular matrix interactions | |
MY146535A (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
TN2010000213A1 (en) | Wise binding antibodies and epitopes | |
MX2009005184A (es) | Compuestos y metodos para inhibir la interaccion de las proteinas bcl con agentes aglutinantes. | |
MX2010004219A (es) | Agentes de enlace de cd19 y usos de los mismos. | |
TW200722588A (en) | Reinforcing strands and composites having improved fire resistance | |
EP2162497A4 (en) | BITUMINOUS BINDER COMPOSITION AND MANUFACTURING METHOD THEREFOR | |
WO2009016043A3 (en) | New albumin binding compositions, methods and uses | |
EA200870265A1 (ru) | Функционально активные антитела | |
MX354099B (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
TN2014000134A1 (en) | Therapeutic peptides | |
MX2009006471A (es) | Anticuerpo anti especifico de linfopoyetina estromal timica de diseño. | |
IL212834A (en) | Preparations containing 37cd-specific linkers, for use in the treatment of B cell or autoimmune cancer and kits | |
TN2010000169A1 (en) | Molecules and methods for modulating complement component | |
IL203943A (en) | A preparation containing peptide for the prevention or treatment of allergy to house dust mites | |
WO2008150485A3 (en) | Erbb2 binding proteins and use thereof | |
MX2012001527A (es) | Composicion inmunogenica que comprende proteinas antigenicas de s. aureus. | |
TN2009000255A1 (en) | Quinazolines for pdk1 inhibition | |
MX354402B (es) | Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos. | |
IL193926A (en) | Antibodies that bind to human alpha5 beta1, preparations that include these antibodies and the use of these antibodies | |
TNSN08258A1 (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
WO2009055074A3 (en) | Erbb2 binding proteins and use thereof | |
MX2009008135A (es) | Uso de histidinato de cromo para tratamiento de alteraciones cardiometabolicas. | |
TW200640496A (en) | Visco-supplement composition and methods |